Pruritis clinical trials at UCSF
1 in progress, 0 open to eligible people
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis
Sorry, in progress, not accepting new patients
Study of the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of KPL-716 in subjects with prurigo nodularis.
San Francisco, California and other locations